Ciavarra R, Kang C Y, Forman J
Fed Proc. 1981 Feb;40(2):222-7.
Studies with many viruses have revealed that viral specific protein synthesis is an obligatory step in generating antigens on target cells for antiviral cytotoxic T lymphocytes. This has been most clearly demonstrated with DI particles, virions that are structurally complete but lack infectious RNA. Adsorption of such particles onto target cell membranes does not render these cells susceptible to lytic attack by antiviral effector cells, unless some viral protein synthesis transpires. However, some viruses, such as Sendai virus, circumvent the requirement for viral protein synthesis via fusion of the viral envelope with the target cell membrane, a process mediated by a specialized fusion protein. Once inserted into the lipid bilayer, it is likely that viral components and self H-2 noncovalently associate so that the complex can be recognized by antiviral cytotoxic T cells. This idea is supported by the demonstration that viral proteins and H-2 containing membrane proteins, incorporated into reconstituted membrane vesicles or liposomes are recognized by cytotoxic T cells. These data further show that native rather than altered viral and H-2 molecules are the moieties recognized. Associations between antigen and H-2 have been detected by a variety of techniques and in some cases are not random but selective; that is, viral antigens perferentially associate with some H-2 alleles and not others. In summary, these findings indicate that although viral antigens are present in the mature virions, these components are not recognized by antiviral killer cells until integrated into the plasma membrane. This may be achieved either through direct fusion of the viral envelope with the target cell or following viral protein synthesis and insertion of viral antigens into the plasma membrane.
对多种病毒的研究表明,病毒特异性蛋白质合成是在靶细胞上产生抗原以供抗病毒细胞毒性T淋巴细胞识别的必要步骤。这一点在缺陷干扰颗粒(DI颗粒)上得到了最清晰的证明,DI颗粒是结构完整但缺乏感染性RNA的病毒粒子。此类颗粒吸附到靶细胞膜上并不会使这些细胞易于受到抗病毒效应细胞的裂解攻击,除非发生了一些病毒蛋白质合成。然而,一些病毒,如仙台病毒,可通过病毒包膜与靶细胞膜融合来规避对病毒蛋白质合成的需求,这一过程由一种特殊的融合蛋白介导。一旦插入脂质双层,病毒成分和自身H-2很可能会非共价结合,从而使该复合物能够被抗病毒细胞毒性T细胞识别。这一观点得到了以下证明的支持:掺入重组膜囊泡或脂质体中的病毒蛋白和含H-2的膜蛋白可被细胞毒性T细胞识别。这些数据进一步表明,被识别的部分是天然的而非改变后的病毒和H-2分子。抗原与H-2之间的结合已通过多种技术检测到,在某些情况下并非随机而是具有选择性;也就是说,病毒抗原优先与某些H-2等位基因结合,而不与其他等位基因结合。总之,这些发现表明,尽管病毒抗原存在于成熟病毒粒子中,但在整合到质膜中之前,这些成分不会被抗病毒杀伤细胞识别。这可以通过病毒包膜与靶细胞的直接融合来实现,也可以在病毒蛋白质合成以及病毒抗原插入质膜之后实现。